These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 17973940

  • 1. Homozygosity of the d3-growth hormone receptor polymorphism is associated with a high total effect of GH on growth and a low BMI in girls with Turner syndrome.
    Binder G, Trebar B, Baur F, Schweizer R, Ranke MB.
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):567-72. PubMed ID: 17973940
    [Abstract] [Full Text] [Related]

  • 2. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
    Binder G, Baur F, Schweizer R, Ranke MB.
    J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
    [Abstract] [Full Text] [Related]

  • 3. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
    Baş F, Darendeliler F, Aycan Z, Çetinkaya E, Berberoğlu M, Sıklar Z, Öcal G, Timirci Ö, Çetinkaya S, Darcan Ş, Gökşen Şimşek D, Bideci A, Cinaz P, Böber E, Demir K, Bereket A, Turan S, Atabek ME, Tütüncüler F, Isbir T, Bozkurt N, Kabataş Eryılmaz S, Uzunhan O, Küçükemre Aydın B, Bundak R.
    Horm Res Paediatr; 2012 Feb; 77(2):85-93. PubMed ID: 22456308
    [Abstract] [Full Text] [Related]

  • 4. Association of the exon 3 deleted/full-length GHR polymorphism with recombinant growth hormone dose in growth hormone-deficient adults.
    Meyer S, Schaefer S, Stolk L, Arp P, Uitterlinden AG, Plöckinger U, Stalla GK, Tuschy U, Weber MM, Weise A, Pfützner A, Kann PH.
    Pharmacogenomics; 2009 Oct; 10(10):1599-608. PubMed ID: 19842933
    [Abstract] [Full Text] [Related]

  • 5. Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH Therapy in Short Small-for-Gestational-Age Children.
    Carrascosa A, Audí L, Esteban C, Fernández-Cancio M, Andaluz P, Gussinyé M, Clemente M, Yeste D, Albisu MA.
    J Clin Endocrinol Metab; 2008 Jan; 93(1):147-53. PubMed ID: 17925340
    [Abstract] [Full Text] [Related]

  • 6. The exon 3-deleted/full-length growth hormone receptor polymorphism did not influence growth response to growth hormone therapy over two years in prepubertal short children born at term with adequate weight and length for gestational age.
    Carrascosa A, Audí L, Fernández-Cancio M, Esteban C, Andaluz P, Vilaró E, Clemente M, Yeste D, Albisu MA, Gussinyé M.
    J Clin Endocrinol Metab; 2008 Mar; 93(3):764-70. PubMed ID: 18160465
    [Abstract] [Full Text] [Related]

  • 7. Different relationships between the first 2 years on growth hormone treatment and the d3-growth hormone receptor polymorphism in short small-for-gestational-age (SGA) children.
    Dörr HG, Bettendorf M, Hauffa BP, Mehls O, Rohrer T, Stahnke N, Pfäffle R, Ranke MB, German KIGS Group.
    Clin Endocrinol (Oxf); 2011 Nov; 75(5):656-60. PubMed ID: 21623854
    [Abstract] [Full Text] [Related]

  • 8. The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome.
    Ko JM, Kim JM, Cheon CK, Kim DH, Lee DY, Cheong WY, Kim EY, Park MJ, Yoo HW.
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):196-202. PubMed ID: 19681916
    [Abstract] [Full Text] [Related]

  • 9. The exon 3-deleted/full-length growth hormone receptor polymorphism does not influence the effect of puberty or growth hormone therapy on glucose homeostasis in short non-growth hormone-deficient small-for-gestational-age children: results from a two-year controlled prospective study.
    Audí L, Carrascosa A, Esteban C, Fernández-Cancio M, Andaluz P, Yeste D, Espadero R, Granada ML, Wollmann H, Fryklund L, Spanish SGA Study Group.
    J Clin Endocrinol Metab; 2008 Jul; 93(7):2709-15. PubMed ID: 18445665
    [Abstract] [Full Text] [Related]

  • 10. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.
    Montefusco L, Filopanti M, Ronchi CL, Olgiati L, La-Porta C, Losa M, Epaminonda P, Coletti F, Beck-Peccoz P, Spada A, Lania AG, Arosio M.
    Clin Endocrinol (Oxf); 2010 May; 72(5):661-7. PubMed ID: 20447065
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
    Li J, Wu W, Liang Y, Luo XP.
    Zhonghua Er Ke Za Zhi; 2018 Nov 02; 56(11):866-870. PubMed ID: 30392213
    [Abstract] [Full Text] [Related]

  • 12. GH receptor d3 polymorphism in Dutch patients with MPHD and IGHD born small or appropriate for gestational age.
    de Graaff LC, Meyer S, Els C, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Jun 02; 68(6):930-4. PubMed ID: 18031312
    [Abstract] [Full Text] [Related]

  • 13. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
    Braz AF, Costalonga EF, Montenegro LR, Trarbach EB, Antonini SR, Malaquias AC, Ramos ES, Mendonca BB, Arnhold IJ, Jorge AA.
    J Clin Endocrinol Metab; 2012 Apr 02; 97(4):E671-7. PubMed ID: 22278433
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone (GH) pharmacogenetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency.
    Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ.
    J Clin Endocrinol Metab; 2006 Mar 02; 91(3):1076-80. PubMed ID: 16291702
    [Abstract] [Full Text] [Related]

  • 15. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.
    Carrascosa A, Esteban C, Espadero R, Fernández-Cancio M, Andaluz P, Clemente M, Audí L, Wollmann H, Fryklund L, Parodi L, Spanish SGA Study Group.
    J Clin Endocrinol Metab; 2006 Sep 02; 91(9):3281-6. PubMed ID: 16804042
    [Abstract] [Full Text] [Related]

  • 16. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
    Jorge AA, Arnhold IJ.
    Horm Res; 2009 Apr 02; 71 Suppl 2():55-63. PubMed ID: 19407498
    [Abstract] [Full Text] [Related]

  • 17. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep 02; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 18. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant.
    Marchisotti FG, Jorge AA, Montenegro LR, Berger K, de Carvalho LR, Mendonca BB, Arnhold IJ.
    Growth Horm IGF Res; 2009 Apr 02; 19(2):179-86. PubMed ID: 19036620
    [Abstract] [Full Text] [Related]

  • 19. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M, Ester W, Auriol F, Molinas C, Fauvel J, Caliebe J, Nugent T, Fryklund L, Ranke MB, Savage MO, Clark AJ, Johnston LB, Hokken-Koelega AC, NESTEGG group.
    Clin Endocrinol (Oxf); 2007 Sep 02; 67(3):457-61. PubMed ID: 17555507
    [Abstract] [Full Text] [Related]

  • 20. Exon 3-deleted genotype of growth hormone receptor (GHRd3) positively influences IGF-1 increase at generation test in children with idiopathic short stature.
    Toyoshima MT, Castroneves LA, Costalonga EF, Mendonca BB, Arnhold IJ, Jorge AA.
    Clin Endocrinol (Oxf); 2007 Oct 02; 67(4):500-4. PubMed ID: 17555512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.